Literature DB >> 9606330

Cutaneous graft-versus-host disease.

S Aractingi1, O Chosidow.   

Abstract

Graft-versus-host disease (GvHD) includes inflammatory and/or fibrosing manifestations that may arise at various times after transplantation of any organ containing lymphoid cells. For the dermatologist, the importance of GvHD is real and current. Indeed, because it has become easier to perform bone marrow transplantation (EMT), the indications of BMT have become broader, making follow-up of patients receiving grafts a widespread practice. Nonetheless, GvHD remains a frequent complication of BMT and its principal target organ is the skin. Furthermore, recent innovations, such as grafting of umbilical cord blood and the mobilization of peripheral blood progenitor cells, will be the source of new questions concerning the development of GvHD under these conditions. Finally, because of its analogies with other spontaneous idiopathic skin diseases, GvHD constitutes a model that may lead to a better understanding of the pathophysiological features of these diseases. In this review, the cutaneous aspects of GvHD are emphasized.

Entities:  

Mesh:

Year:  1998        PMID: 9606330     DOI: 10.1001/archderm.134.5.602

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  24 in total

1.  [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

2.  [Cutaneous graft-versus-host disease].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2003-05       Impact factor: 0.751

Review 3.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

4.  MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease.

Authors:  M Horger; A Boss; W Bethge; C Faul; G Fierlbeck; A Bornemann; C D Claussen; W Vogel
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

5.  A case of chronic cutaneous graft versus host disease with the clinical features of exfoliative dermatitis.

Authors:  Hyo Sang Ahn; Hyun Jeong Park; Jun Young Lee; Baik Kee Cho
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

6.  Bilateral areolar lesions in a patient with acute cutaneous graft-vs-host disease.

Authors:  Lisa N Brunengraber; Maria Turner; Chyi-Chia Richard Lee; Pamela Stratton
Journal:  Arch Dermatol       Date:  2011-04

7.  Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.

Authors:  Shan He; Jina Wang; Koji Kato; Fang Xie; Sooryanarayana Varambally; Shin Mineishi; Rork Kuick; Kazuhiro Mochizuki; Yongnian Liu; Evelyn Nieves; Ram-Shankar Mani; Arul M Chinnaiyan; Victor E Marquez; Yi Zhang
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

8.  An unusual case of malignant thymoma associated graft-versus-host disease.

Authors:  Faye Sara Gishen; Adrian J Tookman
Journal:  BMJ Case Rep       Date:  2009-08-19

9.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

10.  Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Atsuko Nakazawa; Shotaro Iwamoto; Hidemi Toyoda; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.